------------ "Under the Anavex ATM model current retail holders will suffer minimum dilution as capital is raised in the future. " ------------
Then please do tell us why Anavex is seeking authorization to dilute to whatever extent is necessary BEYOND the 20% dilution that they have already authorized.
There is a nice little chart in the following link that references the reputation and track record of Lincoln Park Capital since we are comparing methods of raising capital by pre-revenue biotechs.
Despite your prior statements that LPC is issued shares at market prices that is an inaccurate statement. Please show us all the language in their agreement that backs up your assertion.
Market Data 
Markets 
AI
